Song et al. [26] demonstrated that PRMT1 expression promoted the growth of pancreatic cancer-derived cells both in vitro and in vivo and is significantly correlated with pancreatic ductal adenocarcinoma tumor size and prognosis in postoperative patients. This evidence concerns the gene PRMT1 and pancreatic ductal adenocarcinoma.